US Patent 7325355 Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
Patent 7325355 was granted and assigned to Celgene on February, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Jerome B. Zeldis0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+354 characters)
Article
Patent abstract
Methods and compositions for the prevention and treatment of all forms of atherosclerosis are described. Administration of compounds such as thalidomide, its analogs, hydrolysis products, metabolites, derivatives and precursors as well as additional compounds capable of inhibiting tumor necrosis factor α(TNF-α) are used in the invention.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07325355 Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline US Patent 7325355 Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
Infobox
Patent Number
073253550
Patent Number
73253550
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073253550
Date of Patent
February 5, 2008
0Patent Application Number
112169500
Date Filed
August 30, 2005
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07325355 Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07325355
Date of patent
February 5, 2008
Patent application number
11216950
Date Filed
August 30, 2005
Patent primary examiner
Find more entities like US Patent 7325355 Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
